Support data with Adalimumab in patients with rheumatoid arthritis in Germany

被引：0
|
作者：
Tony, H-P
Hein, G.
Richter, C.
Dockhorn, R.
Spieler, W.
Sprekeler, R.
Zeise E.
Matiba, B.
机构：
[1] Univ Wurzburg, Klin Immunol, Med Klin & Poliklin 2, Wurzburg, Germany
[2] Univ Jena, Innere Med Klin, D-6900 Jena, Germany
[3] Rheumatol Schwerpunktpraxis, Stuttgart, Germany
[4] Rheumatol Schwerpunktpraxis, Weener, Germany
[5] Rheumatol Schwerpunktpraxis, Zerbst, Germany
[6] Rheumatol Schwerpunktpraxis, Zeven, Germany
[7] Abbott, Med Abt, Wiesbaden, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [41] FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis
    Lucia Davila-Fajardo, Cristina
    van der Straaten, Tahar
    Baak-Pablo, Rene
    Medarde Caballero, Catalina
    Cabeza Barrera, Jose
    Huizinga, Tom W.
    Guchelaar, Henk-Jan
    Swen, Jesse J.
    PHARMACOGENOMICS, 2015, 16 (04) : 373 - 381
  • [42] Adalimumab - A review of its use in adult patients with rheumatoid arthritis
    Cvetkovic, Risto S.
    Scott, Lesley J.
    BIODRUGS, 2006, 20 (05) : 293 - 311
  • [43] THE EFFECT OF METHOTREXATE IN TREATMENT WITH ADALIMUMAB AND ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    l'Ami, M.
    Kneepkens, E.
    Krieckaert, C.
    Marsman, A.
    Ruwaard, J.
    Wolbink, G.
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 708 - 709
  • [44] Adalimumab is an effective option in the treatment of patients with refractory rheumatoid arthritis
    不详
    Drugs & Therapy Perspectives, 2005, 21 (4) : 1 - 4
  • [45] TNF PRODUCTION IS REGULATED BY ADALIMUMAB TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS
    Diaz-Torne, C.
    Zamora, C.
    Geli, C.
    Diaz-Lopez, C.
    Ortiz, M. A.
    Moya, P.
    Nieto, J. C.
    Castellvi, I.
    Canto, E.
    Casademont, J.
    Juarez, C.
    Llobet, J. M.
    Vidal, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 225 - 226
  • [46] Workplace impacts of adalimumab (HUMIRA®) in patients with rheumatoid arthritis (RA)
    Birnbaum, Howard
    Pike, Crystal
    Kaufman, Rebecca
    Schiller, Matthew
    Shi, Lizheng
    Sun, Peter
    Ray, Saurabh
    Cifaldi, Mary
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S459 - S459
  • [47] Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
    Genovese, Mark C.
    van Vollenhoven, Ronald F.
    Wilkinson, Bethanie
    Wang, Lisy
    Zwillich, Samuel H.
    Gruben, David
    Biswas, Pinaki
    Riese, Richard
    Takiya, Liza
    Jones, Thomas V.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [48] Infection risk in patients with rheumatoid arthritis treated with etanercept or adalimumab
    Chiang, Yi-Chun
    Kuo, Li-Na
    Yen, Yu-Hsuan
    Tang, Chao-Hsiun
    Chen, Hsiang-Yin
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 116 (03) : 319 - 327
  • [49] Peritoneal tuberculosis in patients with rheumatoid arthritis undergoing adalimumab treatment
    Ortiz Balbuena, Jorge
    Munez Rubio, Elena
    Ramos Martinez, Antonio
    MEDICINA CLINICA, 2017, 149 (08): : 368 - 368
  • [50] Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 9 (Suppl 2)
12345